These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7017317)

  • 21. Drug compliance among self-motivated leprosy patients.
    Girdhar A; Mishra B; Bagga A; Girdhar BK
    Indian J Lepr; 1988 Oct; 60(4):506-9. PubMed ID: 3253330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient compliance with dapsone administration in leprosy.
    Huikeshoven H
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):228-58. PubMed ID: 7024150
    [No Abstract]   [Full Text] [Related]  

  • 23. Certain aspects of dapsone metabolism in leprosy patients as studied by high performance liquid chromatography (HPLC) and qualitative screening tests.
    Raj PP; Aschhoff M; De Wit M; Balakrishnan S; Lilly L
    Indian J Lepr; 1988 Apr; 60(2):215-24. PubMed ID: 3192970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstration of dapsone in urine and serum by ELISA inhibition.
    Huikeshoven H; Landheer JE; van Denderen AC; Vlasman M; Leiker DL; Das PK; Goldring OL; Pondman KW
    Lancet; 1978 Feb; 1(8058):280-1. PubMed ID: 74707
    [No Abstract]   [Full Text] [Related]  

  • 25. Irregularity of treatment in leprosy patients: its magnitude and causes.
    Nigam P; Siddique MI; Pandey NR; Awasthi KN; Sriwastava RN
    Lepr India; 1979 Oct; 51(4):521-32. PubMed ID: 522446
    [No Abstract]   [Full Text] [Related]  

  • 26. ELISA inhibition technique for the demonstration of sulphones in body fluids. I. Sulphones specific antibody-enzyme conjugate.
    Huikeshoven H; de Wit M; Soeters A; Eggelte TA; Landheer JE; Leiker DL
    Lepr Rev; 1979 Dec; 50(4):275-81. PubMed ID: 397386
    [No Abstract]   [Full Text] [Related]  

  • 27. An assessment of dapsone self-administration in Gudiyatham Taluk. How should urinary dapsone/creatinine ratios be used?
    Cates CJ
    Lepr Rev; 1981 Mar; 52(1):55-64. PubMed ID: 7242218
    [No Abstract]   [Full Text] [Related]  

  • 28. Self-administered drug compliance in Nepali leprosy patients.
    Roche PW; Failbus S; Britton W
    Trop Doct; 1989 Apr; 19(2):59-61. PubMed ID: 2734837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urine test to monitor dapsone self-administration in leprosy.
    Huikeshoven H
    Trop Doct; 1984 Apr; 14(2):85. PubMed ID: 6729980
    [No Abstract]   [Full Text] [Related]  

  • 30. Monitoring the regularity of self administration of dapsone by leprosy patients.
    Kumar A; Balakrishnan S
    Lepr India; 1982 Oct; 54(4):664-70. PubMed ID: 7183832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weekly self-medication of leprosy patients monitored by DDS/creatinine ratios in urines.
    Huikeshoven HC; Honhoff C; Van Eys GJ; Anten JG; Mayer JM; Van Helden HP
    Lepr Rev; 1976 Sep; 47(3):201-9. PubMed ID: 966948
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of screening tests for dapsone in urine.
    Irudaya Raj PP; Lourdumary S; Aschhoff M; Balakrishnan S
    Lepr India; 1983 Jul; 55(3):528-38. PubMed ID: 6656210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can the dapsone-creatinine ratio in urine be used to monitor therapy in rural areas?
    Naik SS
    Lepr India; 1978 Jul; 50(3):485-7. PubMed ID: 703270
    [No Abstract]   [Full Text] [Related]  

  • 34. Encouraging results from DDS urine analysis among registered leprosy patients in Wangas, Kenya: an exception that challenges the rule.
    Huikeshoven H; Bijleveld I
    Lepr Rev; 1978 Mar; 49(1):47-52. PubMed ID: 642686
    [No Abstract]   [Full Text] [Related]  

  • 35. Urine tests to monitor the self-administration of dapsone by leprosy patients.
    Ellard GA; Gammon PT; Helmy HS; Rees RJ
    Am J Trop Med Hyg; 1974 May; 23(3):464-70. PubMed ID: 4823797
    [No Abstract]   [Full Text] [Related]  

  • 36. Fluorimetric screening of dapsone in urine for drug trials.
    Balakrishnan S
    Lepr India; 1980 Apr; 52(2):245-8. PubMed ID: 7005540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Instrumental variables in the evaluation of diagnostic test procedures when the true disease state is unknown.
    Nagelkerke NJ; Fidler V; Buwalda M
    Stat Med; 1988 Jul; 7(7):739-44. PubMed ID: 3043622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An investigation of dapsone compliance using an isoniazid-marked formulation.
    Stanley JN; Pearson JM; Ellard GA
    Lepr Rev; 1983 Dec; 54(4):317-25. PubMed ID: 6668985
    [No Abstract]   [Full Text] [Related]  

  • 39. Dapsone compliance in an urban field project.
    Revankar CR; Naik SS; Ganapati R
    Lepr India; 1983 Jan; 55(1):117-21. PubMed ID: 6876753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of a dapsone compliance program in leprosy.
    Piscitelli SC; Danziger LH; Hill C; Slajchert AA; West DP; Fischer JH
    Int J Dermatol; 1993 Mar; 32(3):206-9. PubMed ID: 8444536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.